3 November, 2017
Asthma and COPD are prevalent in Singapore. COPD is a serious respiratory disease that limits airflow to the lungs, and was the 10th leading cause of death and hospital admissions in Singapore last year. Singapore also has one of the highest asthma prevalence in the world, and a startling high mortality rate.
For the purposes of this study, data from 13,000 respiratory patients from Singapore will be collected every year. The data collected will then be used by researchers to create an electronic dashboard for better patient management, by tracking the risk of readmission and treatment plans. These dashboards will be available for healthcare institutions like the Singapore General Hospital and SingHealth Polyclinics to use, and will enable healthcare professionals to identify high-risk patients, predict outcomes and risks, and provide bespoke treatment. The electronic dashboard will also function as a database for research into respiratory diseases.
For more details on the study, you may read the full article here.
For further information, please contact:
Andy Leck, Principal, Baker & McKenzie.Wong & Leow
andy.leck@bakermckenzie.com
